Marvel Biosciences Corp. (MBCOF) - Latest Market Data

Price & Market Data

Price: $0.113

Daily Change: $0.00 / 0.00%

Daily Range: $0 - $0

Market Cap: $7,611,555

Daily Volume: 0

Performance Metrics

1 Week: -5.19%

1 Month: -9.36%

3 Months: 20.79%

6 Months: -14.68%

1 Year: 146.3%

YTD: 11.41%

About Marvel Biosciences Corp. (MBCOF)

Discover the market dynamics of Marvel Biosciences Corp. (MBCOF). The stock stands at 0.113, with its daily performance showing a change of $0.00 / 0.00%. Its market cap is valued at 7,611,555. Explore its 6-month (-14.68%) and 1-week (-5.19%) performance for a quick overview.

Details

Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company's lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer's disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.

Selected stocks

Sumitomo Osaka Cement Co., Ltd. (SUCEF)

TNR Gold Corp. (TRRXF)

Dynasty Gold Corp. (DGDCF)

MARATHON GROUP CORPORATION (PDPR)

University Bancorp, Inc. (UNIB)